View More Recent Stories
-
Alcon (ALC) Tops Q3 EPS by 7c ; Offers Guidance
-
Needham Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon (ALC) call put ratio 10 calls to 1 put with a focus on November 90 calls into quarter results
-
Alcon (ALC) November 90 puts active into quarter results and outlook
-
Why traders should increase exposure to MedTech stocks: KeyBanc
-
Alcon Inc. (ALC) PT Raised to $107 at KeyBanc
-
Redburn-Atlantic Upgrades Alcon Inc. (ALC:SW) (ALC) to Neutral
-
Alcon Inc. (ALC) PT Raised to $104 at BTIG
-
RBC Capital Upgrades Alcon Inc. (ALC:SW) (ALC) to Outperform
-
Citi Reiterates Buy Rating on Alcon Inc. (ALC)
-
CFRA Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)
-
Alcon Inc. (ALC) PT Raised to $110 at Oppenheimer
-
Alcon Inc. (ALC) PT Raised to $110 at Baird
-
Alcon Inc. (ALC) PT Raised to $110 at Mizuho
-
Alcon Inc. (ALC) PT Raised to $105 at Wells Fargo
-
Alcon Inc. (ALC) PT Raised to $98 at BTIG
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
Citi Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)
-
Alcon (ALC) Tops Q2 EPS by 1c; maintains guidance
-
Alcon (ALC) September option implied volatility flat
-
Alcon (ALC) call put ratio 5.2 calls to 1 put into quarter results
-
Morgan Stanley Upgrades Alcon Inc. (ALC) to Equalweight
-
STAAR Surgical said targeted in takeover by larger rival Alcon - source
-
BTIG Reiterates Buy Rating on Alcon Inc. (ALC)
-
Analyst weighs in on current investor sentiment in MedTech sector
-
6 MedTech stocks to own - KeyBanc

